Edition: United Kingdom  
One News Page
“Probably the fastest-access news portal in the world”
> >

Teva Pharm to market medical cannabis inhaler in Israel

Reuters Monday, 28 November 2016
JERUSALEM (Reuters) - Israel's Teva Pharmaceuticals has partnered with Tel Aviv-based Syqe Medical to market in Israel medical cannabis for pain management that is administered with an inhaler.
0
shares
Share on
Facebook
Share on
Twitter
Post on 
Reddit
Share by
Email
 
Source: WBAL - < > Embed

News video: Video: Diversity a top concern for Maryland Medical Cannabis Commission

Video: Diversity a top concern for Maryland Medical Cannabis Commission 02:09

Maryland's Medical Cannabis Commission announced on Monday that it is hiring a diversity consultant.

You Might Like


Other recent news in Health

World Thyroid Day 2017:More than a Quarter of people suffer from Thyroid–SRL analysis of 3 MILLION samplesAhmedabad: A rare surgery on 8-year-old girl from UTTAR PRADESH, who drank acid when she was 1.5 years old, was successful
Estimated 23 million would lose health insurance under REPUBLICAN bill: CBOAFRICA Day 2017: Harnessing Demographic Dividend Through Investment in Youth
AP FACT CHECK: Medicaid a TARGET for cuts despite assuranceTrump's Trip Provides Respite From RUSSIA Controversy
New York’s Famed BROOKLYN BRIDGE Opens on this Day in 1883UK Prime Minister to Raise Issue of MANCHESTER BOMBING Leaks with President Trump
British police stop sharing information with UNITED STATES on Manchester attack - sourceThe Latest: Vermont governor VETOES marijuana bill

Twitter

Environmentally friendly: One News Page is hosted on servers powered solely by renewable energy
© 2017 One News Page Ltd. All Rights Reserved.  |  About us  |  Disclaimer  |  Press Room  |  Terms & Conditions  |  Privacy Policy  |  Content Accreditation
 RSS  |  News for my Website  |  Free news search widget  |  Help  |  Contact us  |  DMCA / Content Removal
How are we doing? Send us your feedback  |   LIKE us on Facebook   FOLLOW us on Twitter   FIND us on Google+